Christina M Dieli-Conwright1,2, Frank C Sweeney1, Kerry S Courneya3, Debu Tripathy4, Nathalie Sami1, Kyuwan Lee1, Thomas A Buchanan5, Darcy Spicer2, Leslie Bernstein6, Joanne E Mortimer7, Wendy Demark-Wahnefried8. 1. Division of Biokinesiology and Physical Therapy, University of Southern California, Los Angeles, California. 2. Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California. 3. Faculty of Kinesiology, Sport, and Recreation, University of Alberta, Edmonton, Alberta, Canada. 4. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 5. Division of Endocrinology and Diabetes, Keck School of Medicine, University of Southern California, Los Angeles, California. 6. Division of Biomarkers of Early Detection and Prevention, Beckman Research Institute, City of Hope, Duarte, California. 7. Division of Medical Oncology and Experimental Therapeutics, City of Hope, Duarte, California. 8. Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama.
Abstract
BACKGROUND: Metabolic syndrome (MSY) is associated with an increased risk of cardiovascular disease, type 2 diabetes, and recurrence in breast cancer survivors (BCS). MSY is 1.5 times more common in Hispanic women compared with non-Hispanic women. Although exercise mitigates MSY in BCS, to the best of the authors' knowledge, few studies to date have focused on minorities. This secondary analysis examined ethnicity as a moderator of the effects of a 16-week aerobic and resistance exercise intervention on MSY, sarcopenic obesity, and serum biomarkers in BCS. METHODS:A total of 100 eligible BCS were randomized to exercise (50 BCS) or usual care (50 BCS). The exercise intervention promoted moderate to vigorous aerobic and resistance exercise 3 times a week for 16 weeks. MSY z scores, sarcopenic obesity, and serum biomarkers were measured at baseline, after the intervention, and at the 28-week follow-up (exercise group only). Linear mixed models adjusted for baseline values of the outcome, age, disease stage, adjuvant treatment, and recent physical activity were used to evaluate effect modification by ethnicity. RESULTS:The study sample was 57% Hispanic BCS (HBCS) and 43% non-Hispanic BCS (NHBCS). HBCS were younger, of greater adiposity, and had been diagnosed with more advanced cancers compared with NHBCS (P<.001). Ethnicity was found to moderate the mean differences in exercise training on triglycerides (-36.4 mg/dL; 95% confidence interval [95% CI],-64.1 to -18.8 mg/dL), glucose (-8.6 mg/dL; 95% CI, -19.1 to -3.0 mg/dL), and C-reactive protein (-3.3 mg/L; 95% CI, -7.3 to -0.9 mg/L). CONCLUSIONS:HBCS appear to have poorer metabolic profiles and therefore may derive relatively larger metabolic changes from exercise compared with NHBCS. Clinical exercise interventions may attenuate existing health disparities across diverse groups of BCS.
RCT Entities:
BACKGROUND:Metabolic syndrome (MSY) is associated with an increased risk of cardiovascular disease, type 2 diabetes, and recurrence in breast cancer survivors (BCS). MSY is 1.5 times more common in Hispanic women compared with non-Hispanic women. Although exercise mitigates MSY in BCS, to the best of the authors' knowledge, few studies to date have focused on minorities. This secondary analysis examined ethnicity as a moderator of the effects of a 16-week aerobic and resistance exercise intervention on MSY, sarcopenic obesity, and serum biomarkers in BCS. METHODS: A total of 100 eligible BCS were randomized to exercise (50 BCS) or usual care (50 BCS). The exercise intervention promoted moderate to vigorous aerobic and resistance exercise 3 times a week for 16 weeks. MSY z scores, sarcopenic obesity, and serum biomarkers were measured at baseline, after the intervention, and at the 28-week follow-up (exercise group only). Linear mixed models adjusted for baseline values of the outcome, age, disease stage, adjuvant treatment, and recent physical activity were used to evaluate effect modification by ethnicity. RESULTS: The study sample was 57% Hispanic BCS (HBCS) and 43% non-Hispanic BCS (NHBCS). HBCS were younger, of greater adiposity, and had been diagnosed with more advanced cancers compared with NHBCS (P<.001). Ethnicity was found to moderate the mean differences in exercise training on triglycerides (-36.4 mg/dL; 95% confidence interval [95% CI],-64.1 to -18.8 mg/dL), glucose (-8.6 mg/dL; 95% CI, -19.1 to -3.0 mg/dL), and C-reactive protein (-3.3 mg/L; 95% CI, -7.3 to -0.9 mg/L). CONCLUSIONS:HBCS appear to have poorer metabolic profiles and therefore may derive relatively larger metabolic changes from exercise compared with NHBCS. Clinical exercise interventions may attenuate existing health disparities across diverse groups of BCS.
Authors: Scott M Grundy; H Bryan Brewer; James I Cleeman; Sidney C Smith; Claude Lenfant Journal: Arterioscler Thromb Vasc Biol Date: 2004-02 Impact factor: 8.311
Authors: Kathryn H Schmitz; Kerry S Courneya; Charles Matthews; Wendy Demark-Wahnefried; Daniel A Galvão; Bernardine M Pinto; Melinda L Irwin; Kathleen Y Wolin; Roanne J Segal; Alejandro Lucia; Carole M Schneider; Vivian E von Gruenigen; Anna L Schwartz Journal: Med Sci Sports Exerc Date: 2010-07 Impact factor: 5.411
Authors: Esther C de Haas; Sjoukje F Oosting; Joop D Lefrandt; Bruce Hr Wolffenbuttel; Dirk Th Sleijfer; Jourik A Gietema Journal: Lancet Oncol Date: 2010-02 Impact factor: 41.316
Authors: E Bonora; G Targher; M Alberiche; R C Bonadonna; F Saggiani; M B Zenere; T Monauni; M Muggeo Journal: Diabetes Care Date: 2000-01 Impact factor: 19.112
Authors: Melinda L Irwin; Shelley S Tworoger; Yutaka Yasui; Bharat Rajan; Lynda McVarish; Kristin LaCroix; Cornelia M Ulrich; Deborah Bowen; Robert S Schwartz; John D Potter; Anne McTiernan Journal: Prev Med Date: 2004-12 Impact factor: 4.018
Authors: A Corina Aycinena; Cristina Valdovinos; Katherine D Crew; Wei Yann Tsai; Jennie M Mata; Rossy Sandoval; Dawn Hershman; Heather Greenlee Journal: J Immigr Minor Health Date: 2017-02
Authors: Johanna L Johnson; Cris A Slentz; Joseph A Houmard; Gregory P Samsa; Brian D Duscha; Lori B Aiken; Jennifer S McCartney; Charles J Tanner; William E Kraus Journal: Am J Cardiol Date: 2007-10-29 Impact factor: 2.778
Authors: Cynthia Owusu; Seunghee Margevicius; Nora L Nock; Kristina Austin; Elizabeth Bennet; Stephen Cerne; Paul Hergenroeder; Halle C F Moore; Jean Petkac; Mark Schluchter; Kathryn H Schmitz; Monica Webb Hooper; Leonard Wimbley; Nathan A Berger Journal: Cancer Date: 2022-03-15 Impact factor: 6.921
Authors: Paola Gonzalo-Encabo; Rebekah L Wilson; Dong-Woo Kang; Mary K Norris; Hajime Uno; Cami N Christopher; Christina Chow; Nathalie Sami; Frank S Fox; Jennifer A Ligibel; Christina M Dieli-Conwright Journal: Front Oncol Date: 2022-05-10 Impact factor: 5.738
Authors: Melinda L Irwin; Diana Lowry; Marian L Neuhouser; Jennifer Ligibel; Kathryn Schmitz; Ruth E Patterson; Graham Colditz; Fangyong Li; Linda Nebeling Journal: Transl Behav Med Date: 2021-03-16 Impact factor: 3.046
Authors: Christina M Dieli-Conwright; Frank S Fox; Debu Tripathy; Nathalie Sami; Jessica Van Fleet; Thomas A Buchanan; Darcy Spicer; Kyuwan Lee; Joanne Mortimer; Leslie Bernstein; Wendy Demark-Wahnefried; Kerry S Courneya Journal: J Cancer Surviv Date: 2020-07-17 Impact factor: 4.442
Authors: Tracy E Crane; Terry A Badger; Patrick O'Connor; Chris Segrin; Alexis Alvarez; Sarah J Freylersythe; Irlena Penaloza; Thaddeus W W Pace; Alla Sikorskii Journal: J Cancer Surviv Date: 2020-11-10 Impact factor: 4.442